Ganglioside GD1a Antibody (IgM), EIA

Understand what Ganglioside GD1a Antibody (IgM), EIA signals

LOINC codes: 21282-9, 10359-8, 13440-3, 13663-0, 21283-7, 2458-8, 2465-3, 2472-9, 25700-6, 43240-1, 43241-9
Commercial laboratory assays: 2

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for Ganglioside GD1a Antibody (IgM), EIA

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

Ganglioside GD1a Antibody (IgM), EIA

Laboratory: Quest Diagnostics
Test code: 38964
Specimen: Serum
Fasting: Not stated
LOINC: 21282-9
Turnaround: Set up: Tues, Thurs

Laboratory assay overview

Ganglioside GD1a antibody IgM is associated with the presence of multifocal motor neuropathy, sometimes in association with IgM monoclonal gammopathy. Antibody testing can aid in the diagnosis of multifocal motor neuropathy or predominantly motor neuropathy.

View complete laboratory reference notes

<1:800 titer

Quest Diagnostics test directory, test code 38964

Motor Neuropathy Complete Antibody Panel

Laboratory: Quest Diagnostics
Test code: 90137
Specimen: Serum
Fasting: Not stated
LOINC: 10359-8, 13440-3, 13663-0, 21282-9, 21283-7, 2458-8, 2465-3, 2472-9, 25700-6, 43240-1, 43241-9

Laboratory assay overview

The panel includes ganglioside antibodies associated with motor neuropathies. Many of the anti-ganglioside antibodies associated with chronic immune neuropathies are monoclonal IgM antibodies. An evaluation for monoclonal gammopathy should be performed in this setting.

View complete laboratory reference notes

See Laboratory Report

Quest Diagnostics test directory, test code 90137

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.